Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BELOVA: A Non-Interventional Study to Collect Data on the Safety and Efficacy of Frontline Bevacizumab Treatment in Ovarian Cancer Patients 70 Years and Older

NCT02393898 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02393898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02393898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BELOVA: A Non-Interventional Study to Collect Data on the Safety and Efficacy of Frontline Bevacizumab Treatment in Ovarian Cancer Patients 70 Years and Older
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 23, 2015
Completion date
June 14, 2019
Enrollment
76 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer